
Global disparities in SARS-CoV-2 genomic surveillance
2022; Nature Portfolio; Volume: 13; Issue: 1 Linguagem: Inglês
10.1038/s41467-022-33713-y
ISSN2041-1723
AutoresAnderson F. Brito, Elizaveta Semenova, Gytis Dudas, Gabriel W. Hassler, Chaney C. Kalinich, Moritz U. G. Kraemer, Joses Ho, Houriiyah Tegally, George Githinji, Charles N. Agoti, Lucy Matkin, Charles Whittaker, Todor Kantardjiev, Nelly Korsun, Savina Stoitsova, Reneta Dimitrova, Ivelina Trifonova, Veselin Dobrinov, Lubomira Grigorova, Ivan Stoykov, Iliana Grigorova, Anna Gancheva, Amy V. Jennison, Lex E.X. Leong, David Speers, Robert Baird, Louise Cooley, Karina Kennedy, Joep de Ligt, William D. Rawlinson, Sebastiaan J. van Hal, Deborah A. Williamson, Risha Singh, Sue-Min Nathaniel-Girdharrie, Lisa Edghill, Lisa Indar, Joy St. John, Gabriel González-Escobar, Vernie Ramkisoon, Arianne Brown Jordan, Anushka Ramjag, Nicholas Mohammed, J. E. Foster, Irad Potter, Sharra Greenaway-Duberry, Kenneth George, Sharon Belmar-George, J. Jack Lee, Jacqueline Bisasor-McKenzie, Nadia Astwood, Rhonda Sealey-Thomas, Hazel Laws, Narine Singh, Ayoola Oyinloye, Pearl McMillan, Avery Hinds, Naresh Nandram, Roshan Parasram, Zobida Khan-Mohammed, Shawn Charles, Aisha Andrewin, D. Barrie Johnson, Simone Keizer-Beache, Chris Oura, Oliver G. Pybus, Nuno R. Faria, Marc Stegger, Mads Albertsen, Anders Fomsgaard, Morten Rasmussen, Ricardo Khouri, Felipe Gomes Naveca, Tiago Gräf, Fábio Miyajima, Gabriel Luz Wallau, Fernando Couto Motta, Shruti Khare, Lucas Freitas, Constanza Schiavina, Gunter Bach, Mark B. Schultz, Yi Hong Chew, Meera Makheja, Priscila Born, Gabriela Calegário, Sofia Romano, Juan Finello, Amadou Diallo, Raphael Tze Chuen Lee, Ya Ni Xu, Winston Yeo, Suma Tiruvayipati, Shilpa Yadahalli, Eduan Wilkinson, Arash Iranzadeh, Jennifer Giandhari, Deelan Doolabh, Sureshnee Pillay, Upasana Ramphal, James Emmanuel San, Nokukhanya Msomi, Koleka Mlisana, Anne von Gottberg, Sibongile Walaza, Arshad Ismail, Thabo Mohale, Susan Engelbrecht, Gert U. van Zyl, Wolfgang Preiser, Alex Sigal, Diana Hardie, Gert Marais, Marvin Hsiao, Stephen N.J. Korsman, Mary‐Ann Davies, Lynn Tyers, Innocent Mudau, Denis York, Caroline Maslo, Dominique Goedhals, Shareef Abrahams, Oluwakemi Laguda-Akingba, Arghavan Alisoltani, Adam Godzik, Constantinos Kurt Wibmer, Darren P. Martin, Richard Lessells, Jinal N. Bhiman, Carolyn Williamson, Túlio de Oliveira, Chaoran Chen, Sarah Nadeau, Louis du Plessis, Christiane Beckmann, Maurice Redondo, Olivier Kobel, Christoph Noppen, Sophie Seidel, Noemie Santamaria de Souza, Niko Beerenwinkel, Ivan Topolsky, Philipp Jablonski, Lara Fuhrmann, David Dreifuss, Katharina Jahn, Pedro Ferreira, Susana Posada-Céspedes, Christian Beisel, Rebecca Denes, Mirjam Feldkamp, Ina Nissen, Natascha Santacroce, Elodie Burcklen, Catharine Aquino, Andreia Cabral de Gouvea, Maria Moccia, Simon Grüter, Timothy Sykes, Lennart Opitz, Griffin White, Laura Neff, Doris Popovic, Andrea Patrignani, Jay Tracy, Ralph Schlapbach, Emmanouil T. Dermitzakis, Keith Harshman, Ioannis Xénarios, Henri Pegeot, Lorenzo Cerutti, Deborah Penet, Tanja Stadler, Benjamin P. Howden, Vitali Sintchenko, Neta S. Zuckerman, Orna Mor, Heather M. Blankenship, Túlio de Oliveira, Raymond Tzer Pin Lin, Marilda Mendonça Siqueira, Paola Cristina Resende, Ana Tereza Ribeiro de Vasconcelos, Fernando Rosado Spilki, Renato Santana Aguiar, Ivailo Alexiev, Ivan Ivanov, Ivva Philipova, Christine V. F. Carrington, Nikita Sahadeo, Ben Branda, Céline Gurry, Sebastian Maurer‐Stroh, Dhamari Naidoo, Karin J. von Eije, Mark D. Perkins, Maria D. Van Kerkhove, Sarah C. Hill, Éster Cerdeira Sabino, Oliver G. Pybus, Christopher Dye, Samir Bhatt, Seth Flaxman, Marc A. Suchard, Nathan D. Grubaugh, Guy Baele, Nuno R. Faria,
Tópico(s)SARS-CoV-2 detection and testing
ResumoAbstract Genomic sequencing is essential to track the evolution and spread of SARS-CoV-2, optimize molecular tests, treatments, vaccines, and guide public health responses. To investigate the global SARS-CoV-2 genomic surveillance, we used sequences shared via GISAID to estimate the impact of sequencing intensity and turnaround times on variant detection in 189 countries. In the first two years of the pandemic, 78% of high-income countries sequenced >0.5% of their COVID-19 cases, while 42% of low- and middle-income countries reached that mark. Around 25% of the genomes from high income countries were submitted within 21 days, a pattern observed in 5% of the genomes from low- and middle-income countries. We found that sequencing around 0.5% of the cases, with a turnaround time <21 days, could provide a benchmark for SARS-CoV-2 genomic surveillance. Socioeconomic inequalities undermine the global pandemic preparedness, and efforts must be made to support low- and middle-income countries improve their local sequencing capacity.
Referência(s)